Diabetic retinal disease (DRD) remains one of the leading causes of preventable vision loss worldwide and continues to represent a major global public health challenge despite remarkable therapeutic advances over the past two decades. Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has revolutionize...
J. Gonzalez-Cortes, J. E. Gonzalez-Cantu, A. Bilgic et al.· Pharmaceutics· 0 citations
INTRODUCTION
The aim of this work is to evaluate the early real-world effectiveness, anatomical outcomes, and safety of intravitreal aflibercept 8 mg in neovascular aged-related macular degeneration (nAMD) eyes.
METHODS
This retrospective single-center study included consecutive nAMD eyes treated with at least one af...
J. Fricker, L. Sejournet, J. Prange et al.· Ophthalmology and Therapy· 0 citations
Uveitis encompasses a heterogeneous spectrum of etiologies, including systemic inflammatory diseases, infections, specific ophthalmologic entities, and pseudo-uveitis. The diagnostic approach relies on an algorithmic strategy aimed at the early identification of a curable etiology and/or an underlying condition suitabl...
R. Jacquot, T. El-Jammal, Y. Jamilloux et al.· La Revue de medecine interne· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
